Australian Medical Association Pushes Legislation Against E-cigarette Behavior

Regulations by 2FIRSTS.ai
May.27.2024
Australian Medical Association Pushes Legislation Against E-cigarette Behavior
Australia Medical Association pushes for legislation to combat e-cigarette use, facing opposition within government parties. Vote to take place in June.

According to The Guardian on May 26th, the Australian Medical Association is pushing for parliament in Canberra to pass legislation to combat e-cigarette use. The bill is expected to be voted on in June. The ban proposed by the Australian Labor Party on the import and commercial ownership of e-cigarettes is facing obstacles.

 

According to reports, the Australian National Party is hoping to legislate similar restrictions on e-cigarette behavior as tobacco, without the need for a prescription, while also enforcing the same regulations on packaging and taxes. The Australian Liberal Party sometimes allows its smaller coalition partners to dictate the course, and Peter Dutton has expressed dissatisfaction with the ban. However, the party's Minister for Market Education, Sarah Henderson, and others have publicly criticized e-cigarette behavior, describing it as a "menace" in schools.

 

Overall, crossing party lines and working with the Greens is often the safest route in the Senate. In May of this year, the Greens' health spokesperson Jordon Steele-John agreed with a recent survey report that the bill should be passed. However, he cautioned in other comments that the Greens do not "support banning e-cigarettes for adults."

 

This may include revising laws to ensure that individuals are not criminalized for possession, providing adequate support for smoking cessation, and restricting advertising of e-cigarettes to doctors. The party will decide on its stance in the next two weeks.

 

According to reports, the President of the Australian Medical Association, Steve Robson, has given a direct message to lawmakers who "seem more willing to listen to tobacco lobbying groups and political donors than to parents, health departments, and children." He stated, "We hope to encourage the opposition party and others to do the right thing, not listen to donors, and protect Australia's children from the dangers of e-cigarettes.

 

He expressed being "shocked" and "disappointed" to reporters in Canberra, as the National Party is seeking to tax e-cigarettes instead of banning non-prescription e-cigarettes. He also posed serious questions to the Greens party.

 

He believes, "The Green Party is a political party that places the future of the next generation at the core of its policies, which is obviously something they should support, if they truly prioritize the health and well-being of children.

 

Robson asked Health Minister Mark Butler if the regulation of e-cigarettes is stricter than tobacco, despite the latter being more harmful. In order to prevent this situation, is it possible that restrictions on tobacco based on birth year, similar to what New Zealand has attempted, may be implemented.

 

Butler said at the National Press Club conference in May 2023 that the difference is that "tobacco has been with us for too long," while e-cigarettes are still "relatively new." He said, "If we knew then what we know now about the introduction of tobacco, I hope the government would have taken immediate action, just as I now want to tackle e-cigarettes. We have an opportunity now, with e-cigarettes becoming so widespread, accepted, and normalized...to seize this moment before taking any action becomes extremely difficult.

 

Everyone agrees that children should not use e-cigarettes, but that does not mean burdening legislation with the most stringent possible methods. If the goal is not to criminalize a particular group of individuals, then the relevant laws should be revised to ensure that this does not happen. If we had known the current situation when introducing tobacco, the government may have immediately banned tobacco, just as it is now aiming to address e-cigarettes.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
UK Directors Banned After 352,688 Vapes Imported From China Were Misdeclared as Medical Nebulizers in £15 Million Tax Case
The UK Insolvency Service said YSK Enterprises imported large quantities of vapes from China in 2023, with a shipment addressed to the company declared as medical nebulizers before Border Force found 352,688 vaping products. HMRC calculated nearly £15 million ($20.3 million) in unpaid VAT and customs duty, alongside about £437,000 in corporation tax. Two directors were disqualified for nine years. The case predates the UK's Vaping Products Duty, which will introduce vape-specific excise and duty-stamp requirements from October 2026.
Regulations
Sep.11
EU Trade Department Faces Scrutiny Over Contacts With Tobacco Industry
EU Trade Department Faces Scrutiny Over Contacts With Tobacco Industry
European Ombudswoman Teresa Anjinho has opened an inquiry into how the European Commission’s Directorate-General for Trade handles interactions with the tobacco industry. The case follows a complaint from a civil society organisation that alleges regular, unnecessary and non-transparent contacts between DG TRADE and tobacco industry representatives, raising questions over compliance with the EU’s obligations under the WHO Framework Convention on Tobacco Control. The inquiry remains ongoing, and the Ombudswoman has not reached any finding of maladministration.
Aug.24
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Product | PMJ Adds Bold Ruby to IQOS ILUMA i Lineup in Japan, Convenience-Store Rollout Starts Sept. 29
Philip Morris Japan (PMJ) launched Bold Ruby as a new regular color for the IQOS ILUMA i and IQOS ILUMA i ONE in Japan on September 16, 2026, priced at JPY 6,980 and JPY 3,980, respectively. Initial sales began through IQOS online and physical channels, with convenience stores and selected tobacco retailers set to follow from September 29. Bold Ruby is a regular rather than limited-edition colorway and is available for the ILUMA i and ILUMA i ONE, but not the ILUMA i PRIME. The release does not involve changes to the devices' core hardware or functions.
Sep.22
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
FDA Grants PMTA Authorization to 11 ZYN ULTRA Nicotine Pouches, Bringing Total Authorized Pouches to 43
The U.S. Food and Drug Administration authorized 11 ZYN ULTRA nicotine pouch products made by Swedish Match USA through the premarket tobacco product application pathway on August 21, 2026. Ten of the authorized products have a labeled nicotine content of 9 mg, while ZYN ULTRA Smooth was authorized at 11 mg. The reviews were conducted through FDA’s nicotine pouch PMTA pilot program. FDA has now authorized 43 nicotine pouch products, including 23 through the pilot.
Aug.24
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
NAS 2026 | Cliff Douglas: Risk Continuum Should Play a Central Role in Tobacco Policy
Cliff Douglas, a veteran U.S. tobacco-control and public health policy figure, told NAS 2026 that the “continuum of risk” should play a central role in tobacco policy. He called for clearer market pathways, stronger risk communication, differentiated regulation and enforcement, and said possible FDA reforms to PMTA reviews could be a “welcome correction” if they create a more efficient, predictable route for scientifically substantiated lower-risk products. Read 2Firsts’ on-site coverage.
Sep.26
Philippines Mandates Safety Certification for Nicotine Pouches, Gives Industry 12 Months to Comply
Philippines Mandates Safety Certification for Nicotine Pouches, Gives Industry 12 Months to Comply
The Philippines Department of Trade and Industry has placed nicotine pouches under mandatory product certification through Department Administrative Order No. 26-07, Series of 2026. Nicotine pouches must obtain a Philippine Standard, or PS, license before they can be manufactured, imported, packed, distributed or sold in the country. The regime requires testing for nicotine content, pH and water activity, while packaging must disclose nicotine strength, ingredients, allergens, batch information, the PS certification mark and prescribed health warnings. Existing market participants have a 12-month transition period to comply.
Regulations
Oct.12